Abstract
Original language | Undefined/Unknown |
---|---|
Journal | PLoS Genetics (print) |
Volume | 10 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2014 |
Research programs
- EMC MM-03-24-01
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: PLoS Genetics (print), Vol. 10, No. 4, 2014.
Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
AU - Osorio, A
AU - Milne, RL
AU - Kuchenbaecker, K
AU - Vaclova, T
AU - Pita, G
AU - Alonso, R
AU - Peterlongo, P
AU - Blanco, I
AU - de la Hoya, M
AU - Duran, M (Mercedes)
AU - Diez, O
AU - Cajal, TRY
AU - Konstantopoulou, I
AU - Martinez-Bouzas, C
AU - Conejero, RA
AU - Soucy, P
AU - McGuffog, L
AU - Barrowdale, D
AU - van der Lee, A
AU - Arver, B
AU - Rantala, J
AU - Loman, N
AU - Ehrencrona, H
AU - Olopade, OI
AU - Beattie, MS
AU - Domchek, SM
AU - Nathanson, K
AU - Rebbeck, TR
AU - Arun, BK
AU - Karlan, BY
AU - Walsh, C
AU - Lester, J
AU - John, EM
AU - Whittemore, AS
AU - Daly, MB
AU - Southey, M
AU - Hopper, J
AU - Terry, MB
AU - Buys, SS
AU - Janavicius, R
AU - Dorfling, CM
AU - van Rensburg, EJ
AU - Steele, L
AU - Neuhausen, SL
AU - Ding, YC
AU - Hansen, TVO
AU - Jonson, L
AU - Ejlertsen, B
AU - Gerdes, AM
AU - Infante, M
AU - Herraez, B
AU - Moreno, LT
AU - Weitzel, JN
AU - Herzog, J
AU - Weeman, K
AU - Manoukian, S
AU - Peissel, B
AU - Zaffaroni, D
AU - Scuvera, G
AU - Bonanni, B
AU - Mariette, F
AU - Volorio, S
AU - Viel, A
AU - Varesco, L
AU - Papi, L
AU - Ottini, L
AU - Tibiletti, MG
AU - Radice, P
AU - Yannoukakos, D
AU - Garber, J
AU - Ellis, S
AU - Frost, D
AU - Platte, R
AU - Fineberg, E
AU - Evans, G
AU - Lalloo, F
AU - Izatt, L
AU - Eeles, R
AU - Adlard, J
AU - Davidson, R
AU - Cole, T
AU - Eccles, D
AU - Cook, J
AU - Hodgson, S
AU - Brewer, C
AU - Tischkowitz, M
AU - Douglas, F
AU - Porteous, M
AU - Side, L
AU - Walker, L
AU - Morrison, P
AU - Donaldson, A
AU - Kennedy, J
AU - Foo, C
AU - Godwin, AK
AU - Schmutzler, RK
AU - Wappenschmidt, B
AU - Rhiem, K
AU - Engel, C
AU - Meindl, A
AU - Ditsch, N
AU - Arnold, N
AU - Plendl, HJ
AU - Niederacher, D
AU - Sutter, C
AU - Wang-Gohrke, S
AU - Steinemann, D
AU - Preisler-Adams, S
AU - Kast, K
AU - Varon-Mateeva, R
AU - Gehrig, A
AU - Stoppa-Lyonnet, D
AU - Sinilnikova, OM
AU - Mazoyer, S
AU - Damiola, F
AU - Poppe, B
AU - Claes, K
AU - Piedmonte, M
AU - Tucker, K
AU - Backes, F
AU - Rodriguez, G
AU - Brewster, W
AU - Wakeley, K
AU - Rutherford, T
AU - Caldes, T
AU - Nevanlinna, H
AU - Aittomaki, K
AU - Rookus, MA
AU - van Os, TAM
AU - van der Kolk, L
AU - de Lange, JL
AU - Meijers-Heijboer, HEJ
AU - van der Hout, AH
AU - van Asperen, CJ
AU - Garcia, EBG
AU - Hoogerbrugge, N
AU - Collee, Margriet
AU - van Deurzen, Carolien
AU - van der Luijt, RB
AU - Devilee, P
AU - Olah, E
AU - Lazaro, C (Conxi)
AU - Teule, A
AU - Menendez, M
AU - Jakubowska, A
AU - Cybulski, C
AU - Gronwald, J
AU - Lubinski, J
AU - Durda, K
AU - Jaworska-Bieniek, K
AU - Johannsson, OT
AU - Maugard, C
AU - Montagna, M
AU - Tognazzo, S
AU - Teixeira, MR
AU - Healey, S
AU - Olswold, C
AU - Guidugli, L
AU - Lindor, N
AU - Slager, S
AU - Szabo, CI
AU - Vijai, J
AU - Robson, M
AU - Kauff, N
AU - Zhang, LY
AU - Rau-Murthy, R
AU - Fink-Retter, A
AU - Singer, CF
AU - Rappaport, C
AU - Kaulich, DG
AU - Pfeiler, G
AU - Tea, MK
AU - Berger, A
AU - Phelan, CM
AU - Greene, MH
AU - Mai, PL
AU - Lejbkowicz, F
AU - Andrulis, I
AU - Mulligan, AM
AU - Glendon, G
AU - Toland, AE
AU - Bojesen, A
AU - Pedersen, IS
AU - Sunde, L
AU - Thomassen, Marga
AU - Kruse, TA
AU - Jensen, UB
AU - Friedman, E
AU - Laitman, Y
AU - Shimon, SP
AU - Simard, J
AU - Easton, DF
AU - Offit, K
AU - Couch, FJ
AU - Chenevix-Trench, G
AU - Antoniou, AC
AU - Benitez, J
PY - 2014
Y1 - 2014
N2 - Single Nucleotide Polymorphisms (SNPs) in genes involved in the DNA Base Excision Repair (BER) pathway could be associated with cancer risk in carriers of mutations in the high-penetrance susceptibility genes BRCA1 and BRCA2, given the relation of synthetic lethality that exists between one of the components of the BER pathway, PARP1 (poly ADP ribose polymerase), and both BRCA1 and BRCA2. In the present study, we have performed a comprehensive analysis of 18 genes involved in BER using a tagging SNP approach in a large series of BRCA1 and BRCA2 mutation carriers. 144 SNPs were analyzed in a two stage study involving 23,463 carriers from the CIMBA consortium (the Consortium of Investigators of Modifiers of BRCA1 and BRCA2). Eleven SNPs showed evidence of association with breast and/or ovarian cancer at p<0.05 in the combined analysis. Four of the five genes for which strongest evidence of association was observed were DNA glycosylases. The strongest evidence was for rs1466785 in the NEIL2 (endonuclease VIII-like 2) gene (HR: 1.09, 95% CI (1.03-1.16), p = 2.7x10(-3)) for association with breast cancer risk in BRCA2 mutation carriers, and rs2304277 in the OGG1 (8-guanine DNA glycosylase) gene, with ovarian cancer risk in BRCA1 mutation carriers (HR: 1.12 95% CI: 1.03-1.21, p = 4.8x10(-3)). DNA glycosylases involved in the first steps of the BER pathway may be associated with cancer risk in BRCA1/2 mutation carriers and should be more comprehensively studied.
AB - Single Nucleotide Polymorphisms (SNPs) in genes involved in the DNA Base Excision Repair (BER) pathway could be associated with cancer risk in carriers of mutations in the high-penetrance susceptibility genes BRCA1 and BRCA2, given the relation of synthetic lethality that exists between one of the components of the BER pathway, PARP1 (poly ADP ribose polymerase), and both BRCA1 and BRCA2. In the present study, we have performed a comprehensive analysis of 18 genes involved in BER using a tagging SNP approach in a large series of BRCA1 and BRCA2 mutation carriers. 144 SNPs were analyzed in a two stage study involving 23,463 carriers from the CIMBA consortium (the Consortium of Investigators of Modifiers of BRCA1 and BRCA2). Eleven SNPs showed evidence of association with breast and/or ovarian cancer at p<0.05 in the combined analysis. Four of the five genes for which strongest evidence of association was observed were DNA glycosylases. The strongest evidence was for rs1466785 in the NEIL2 (endonuclease VIII-like 2) gene (HR: 1.09, 95% CI (1.03-1.16), p = 2.7x10(-3)) for association with breast cancer risk in BRCA2 mutation carriers, and rs2304277 in the OGG1 (8-guanine DNA glycosylase) gene, with ovarian cancer risk in BRCA1 mutation carriers (HR: 1.12 95% CI: 1.03-1.21, p = 4.8x10(-3)). DNA glycosylases involved in the first steps of the BER pathway may be associated with cancer risk in BRCA1/2 mutation carriers and should be more comprehensively studied.
U2 - 10.1371/journal.pgen.1004256
DO - 10.1371/journal.pgen.1004256
M3 - Article
C2 - 24698998
SN - 1553-7390
VL - 10
JO - PLoS Genetics (print)
JF - PLoS Genetics (print)
IS - 4
ER -